Revolution Medicines presents updated cancer drug trial data at AACR
Revolution Medicines Inc. (NASDAQ: RVMD) will present updated clinical data for its cancer drug daraxonrasib at the American Association for ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)